Warning: This page contains discussions of eating disorders, which some readers may find upsetting.
Avery, an American singer-songwriter, uploaded two videos on her social media sites urging followers ‘to be careful’ using Ozempic unless prescribed.
Avery, whose true name is Anna Iannitelli, recently posted a video on Instagram claiming she had been diagnosed with osteoporosis after supposedly taking Ozempic for a year.
Ozempic is a weekly injectable that helps reduce blood sugar levels in your body by stimulating the pancreas to produce more insulin. In 2017, the United States licensed it for use in individuals with type 2 diabetes.
According to UC Davis Health, the University of California’s medical center, Ozempic is not licensed for weight reduction, but a medicine known as Wegovy is, which has a higher dose of semaglutide and is covered by both Ozempic and Wegovy.
According to Diabetes UK, people with type 2 diabetes can take Ozempic, and the National Institute for Health and Care Excellence (NICE) recommends it be administered if “using three drugs has not been helpful” or “you have not been able to take the prescriptions.”
In her first social media post, Avery stated that she had gone for a checkup since she had ‘been off Ozempic for two months now’ and wanted to see if her body was in ‘better shape.'”.
However, she claims she was left ‘in shock’ when she was told she had osteoporosis, which, according to the Mayo Clinic, can cause bones to ‘become weak and brittle—so brittle that a fall or even slight stressors such as leaning over or coughing might cause a break.’.
She adds that she ‘wasn’t anticipating this,’ saying, “I guess Ozempic may cause bone density loss, and I didn’t believe it would happen to me, because I was only on medication for a year, but I have considerable bone loss.
“I have osteoporosis and osteopenias that I do not understand. I have a few of these, and I was simply… I honestly wasn’t prepared for that.
She stated in her description that she did not receive a doctor’s prescription, citing the ease of obtaining one these days, and that she suffers from an eating disorder.
I made a mistake. I accept responsibility for my conduct. Please learn from my mistakes,” she stated, adding that she would take medicine and implement a treatment plan.
“Please, please, please be careful with Ozempic if you are not someone that needs to take it.” Avery continued.
In a follow-up video, she stated that she was not seeking to “demonize” Ozempic and instead wants to “make people aware of what can happen” when it is used unprescribed.
A spokeswoman for Novo Nordisk, the company behind Ozempic, informed UNILAD, “Novo Nordisk does not condone, suggest, or encourage the misuse of any of our medicines outside of their approved indications.” Ozempic (semaglutide injectable) is not approved for the treatment of weight reduction.
Посмотреть эту публикацию в Instagram
“We recognize the health issues this individual has endured, and the safety and well-being of individuals who use our medications is our top focus.
“We strongly recommend that all patients stay in close contact with their healthcare professional for proper diagnosis, ongoing guidance, and careful monitoring.”
They said, “It is crucial to remember that Ozempic (semaglutide injection) is a prescription-only treatment, which means a healthcare practitioner must provide it under tight supervision.
To determine if a prescription is appropriate based on the patient’s unique medical profile, patients must discuss treatment decisions with their doctor.
“Accessing prescription-only medicines without a valid prescription or the care of a healthcare professional can pose a direct danger to health.”